Skip to main content

What the FDA labels say about taking them together

Cyclosporine and nevirapine

Nevirapine's FDA label of July 15, 2026 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name nevirapine. The nevirapine label: “Immunosuppressants: Cyclosporine, tacrolimus, sirolimus Plasma concentrations may be decreased.”

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the nevirapine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.).

What does the cyclosporine label say about nevirapine?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name nevirapine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the nevirapine label say about cyclosporine?

Nevirapine label, drug interactions

Immunosuppressants: Cyclosporine, tacrolimus, sirolimus Plasma concentrations may be decreased.

Source: FDA drug label (Nevirapine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set c6e93829-7024-48f6-8023-da6ff27dfc0a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
6Nevirapine generic labelers
CyclosporineNevirapine
Labeled forOrgan transplant rejection, Rheumatoid arthritisHIV
Boxed warningYesYes
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsion$0.147 per tablet 200 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?